Reviva Pharmaceuticals Holdings annual current ratio
2019
2020
2022
2023
2024
2025
Reviva Pharmaceuticals Holdings Current Ratio Growth & History (RVPH)
Reviva Pharmaceuticals Holdings's current ratio was 2.08 for fiscal 2025.
View full Reviva Pharmaceuticals Holdings company overviewReviva Pharmaceuticals Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.08 | 1.07 | +106.43% |
| 2024 | 2024-12-31 | 1.01 | −0.37 | −27.13% |
| 2023 | 2023-12-31 | 1.38 | −0.52 | −27.36% |
| 2022 | 2022-12-31 | 1.90 | — | — |
| 2020 · Feb 29 | 2020-02-29 | 0.46 | −17.07 | −97.36% |
| 2019 · Feb 28 | 2019-02-28 | 17.53 | — | — |
Reviva Pharmaceuticals Holdings quarterly current ratio
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 3.56 | 2.67 | +297.88% |
| Q1 2026 | 2026-03-31 | 3.85 | 3.31 | +608.17% |
| Q4 2025 | 2025-12-31 | 2.08 | 1.07 | +106.43% |
| Q3 2025 | 2025-09-30 | 1.39 | 1.00 | +257.26% |
| Q2 2025 | 2025-06-30 | 0.90 | 0.38 | +72.64% |
| Q1 2025 | 2025-03-31 | 0.54 | — | — |
| Q4 2024 | 2024-12-31 | 1.01 | −0.37 | −27.13% |
| Q3 2024 | 2024-09-30 | 0.39 | — | — |
| Q2 2024 | 2024-06-30 | 0.52 | — | — |
| Q4 2023 | 2023-12-31 | 1.38 | — | — |
| Q3 2021 · Nov 30 | 2020-11-30 | 0.05 | −1.45 | −96.57% |
| Q2 2021 · Aug 31 | 2020-08-31 | 0.05 | −7.31 | −99.30% |
| Q1 2021 · May 31 | 2020-05-31 | 0.48 | −11.72 | −96.08% |
| Q4 2020 · Feb 29 | 2020-02-29 | 0.46 | −17.07 | −97.36% |
| Q3 2020 | 2019-11-30 | 1.50 | −19.10 | −92.73% |
| Q2 2020 | 2019-08-31 | 7.36 | −334.59 | −97.85% |
| Q1 2020 | 2019-05-31 | 12.20 | — | — |
| Q4 2019 · Feb 28 | 2019-02-28 | 17.53 | — | — |
| Q3 2019 | 2018-11-30 | 20.60 | — | — |
| Q2 2019 | 2018-08-31 | 341.95 | — | — |
Reviva Pharmaceuticals Holdings current ratio trends
Between the periods ended 2019-02-28 and 2025-12-31, Reviva Pharmaceuticals Holdings's current ratio decreased from 17.53 to 2.08, a change of −15.46. The latest reported quarter, Q2 2026, shows 3.56.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Reviva Pharmaceuticals Holdings source filings ↗